CLINICAL_TRIALS
trial_result
· 2015-10-20
Clinical Trial Update: BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC) [Phase 2]
Summary
Phase 2 trial update for BMS-936558 (MDX-1106) in advanced/metastatic clear-cell renal cell carcinoma completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2015-10-20